Price $6.00 |
Market Cap
364.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
3.02
|
P/S
26.2
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-52.1K
|
FCF
-0.9
|
|
Op. Margin
-
|
Net Margin
-480.40%
|
ROE
-50.70%
|
ROI
-
|
|
ROA
-41.90%
|
EPS Growth
49.50%
|
Current Ratio
9.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | $1.78 | - | - | 109.5M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $23.73 | - | - | 9.88B | Strong Buy |
| Biocept Inc (BIOC) | $3.77 | - | - | 56.2M | Strong Buy |
| Akumin Inc (AKU) | $1.54 | - | - | 195.6M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.40 | - | - | 93.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
